Jon Napitupulu

Cosmos Health posted record third-quarter results, with revenue up 38% year over year to $17.1 million, gross profit more...

INVO Fertility reported third-quarter 2025 revenue of $1.76 million, up 23% year over year, with consolidated clinic revenue from...

Genfit reported third-quarter 2025 financials with cash and equivalents at €119.0 million and nine-month revenue of €39.2 million, driven...

Nanobiotix has closed a non-dilutive royalty financing with HealthCare Royalty worth up to $71 million, delivering a $50 million...

Ocular Therapeutix has granted inducement equity awards to eight newly hired non-executive employees under its 2019 inducement stock incentive...

Novo Nordisk has closed its acquisition of Akero Therapeutics for $54 per share in cash, valuing the deal at...

Japan’s Ministry of Health, Labour and Welfare has approved Dupixent (dupilumab) for children aged 6 to 11 with severe...

FDA has approved two denosumab biosimilars from the Amneal–mAbxience partnership: Boncresa, referencing Prolia for osteoporosis and related uses, and...

Eurobio Scientific will ask shareholders on January 26, 2026 to approve the replacement of its statutory auditor, Endrix Lyo,...

Rectify Pharmaceuticals has signed a strategic research and licensing agreement with Boehringer Ingelheim to develop oral small molecules that...